Galecto Biotech AB
Records under this name other than the patents Galecto Biotech AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,243,021 | Galactoside inhibitor of galectins Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,580,456 | Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,406,655 | Once-Daily Treatment of Pulmonary Fibrosis Lapsed on the fee record Ended Aug 9, 2026 · High confidence | Lapsed on the fee record | Ended Aug 9, 2026 | High confidence |
| US 8,697,862 | Synthesis of galactoside inhibitors Lapsed on the fee record Ended Apr 15, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2026 | From the USPTO record |
| US 9,688,713 | Galactoside inhibitor of galectins Formerly held Lapsed on the fee record Ended Jun 27, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 27, 2025 | From the USPTO record |
| US 10,800,804 | Hybrid galactoside inhibitor of galectins Lapsed on the fee record Ended Oct 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 13, 2024 | From the USPTO record |
| US 9,353,141 | Galectoside inhibitors of galectins Lapsed on the fee record Ended May 31, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2024 | From the USPTO record |
| US 10,253,059 | Hybrid galactoside inhibitor of galectins Lapsed on the fee record Ended Apr 9, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 9, 2023 | From the USPTO record |
| US 8,703,720 | Galactoside inhibitors of galectins Lapsed on the fee record Ended Apr 22, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2022 | From the USPTO record |
| US 7,700,763 | 3-triazolyl-galactoside inhibitors of galectins Lapsed on the fee record Ended Apr 20, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 20, 2022 | From the USPTO record |